GSDMC and cancer: PRGs with consistent enhanced expression and association with poor survival in cancers included GSDMC in BRCA, KIRC, LIHC, PAAD, UVM and KICH; DFNA5 (GSDME) in COAD, STAD, UCEC, HNSC, KIRC; and AIM2 in KIRP, KIRC, UVM, and PAAD.